Dispersion of nanomaterials used in toxicological studies: a comparison of sonication approaches demonstrated on TiO2 P25

Toxicological testing of nanomaterials often involves in vitro studies of nanoscale powders, which, therefore, need to be dispersed. Various dispersion approaches have been described in the literature, with the main differences between them being the sonication method, the medium, and the additives used. In the present study, five dispersion approaches were compared using titanium dioxide nanoparticles (Aeroxide TiO2 P25). Three of the selected approaches were two- or multi-step processes consisting of dispersion in water followed by transfer to cell culture media, while the two other procedures include only the dispersion in water or in media. One approach was based on bath sonication, whereas the others used direct sonication through insertion of a probe into the sample. The main finding arising out of the comparison of the direct dispersion methods was that the specific energy input played a crucial role in determining the achievable particle size (133–182 nm). A low volume of liquid and a relatively low power in conjunction with a long pulsed dispersion time were found to be favorable for minimizing the side effects of ultrasonication like radical formation or material degradation. The resulting size in the cell culture media showed a strong dependence on the dilution method. Predilution with water before addition to the media prevented the agglomeration of the TiO2 particles under physiological conditions. Direct dispersion in media resulted in the smallest dispersible size. This study succeeded in furthering the understanding of the dispersion process and yielded useful tips for avoiding pitfalls in the preparation of suspensions for toxicological experiments.

[1]  T. Xia,et al.  Toxic Potential of Materials at the Nanolevel , 2006, Science.

[2]  M. Wiesner,et al.  A standardised approach for the dispersion of titanium dioxide nanoparticles in biological media , 2013, Nanotoxicology.

[3]  Sumit Arora,et al.  Nanotoxicology and in vitro studies: the need of the hour. , 2012, Toxicology and applied pharmacology.

[4]  John T Elliott,et al.  Stable nanoparticle aggregates/agglomerates of different sizes and the effect of their size on hemolytic cytotoxicity , 2011, Nanotoxicology.

[5]  Aleksandr B Stefaniak,et al.  “Real-world” precision, bias, and between-laboratory variation for surface area measurement of a titanium dioxide nanomaterial in powder form , 2013, Journal of Nanoparticle Research.

[6]  Alok Dhawan,et al.  Nanomaterials: A challenge for toxicologists , 2009 .

[7]  Monika Maier,et al.  Does Lung Surfactant Promote Disaggregation of Nanostructured Titanium Dioxide? , 2006, Journal of occupational and environmental medicine.

[8]  M. Morille,et al.  Implication of oxidative stress in size-dependent toxicity of silica nanoparticles in kidney cells. , 2012, Toxicology.

[9]  Annegret Potthoff,et al.  Physico-chemical characterization in the light of toxicological effects , 2009, Inhalation toxicology.

[10]  Lei Wang,et al.  Sonocatalytic damage of bovine serum albumin (BSA) in the presence of nanometer anatase titanium dioxide (TiO2). , 2006, Ultrasound in medicine & biology.

[11]  Philip Demokritou,et al.  Interactions of engineered nanomaterials in physiological media and implications for in vitro dosimetry , 2013, Nanotoxicology.

[12]  W. Stark,et al.  The degree and kind of agglomeration affect carbon nanotube cytotoxicity. , 2007, Toxicology letters.

[13]  E. Grulke,et al.  Breakage of TiO2 agglomerates in electrostatically stabilized aqueous dispersions , 2005 .

[14]  Mark R. Wiesner,et al.  Ultrasonic dispersion of nanoparticles for environmental, health and safety assessment – issues and recommendations , 2011, Nanotoxicology.

[15]  Sara Linse,et al.  Understanding the nanoparticle–protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles , 2007, Proceedings of the National Academy of Sciences.

[16]  Julie W. Fitzpatrick,et al.  Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy , 2005, Particle and Fibre Toxicology.

[17]  Vicki H. Grassian,et al.  Silver nanoparticles in simulated biological media: a study of aggregation, sedimentation, and dissolution , 2011 .

[18]  Kenneth A. Dawson,et al.  Protein–Nanoparticle Interactions , 2008, Nano-Enabled Medical Applications.

[19]  Maria Dusinska,et al.  Impact of agglomeration and different dispersions of titanium dioxide nanoparticles on the human related in vitro cytotoxicity and genotoxicity. , 2012, Journal of environmental monitoring : JEM.

[20]  Alison Elder,et al.  Correlating physico-chemical with toxicological properties of nanoparticles: the present and the future. , 2010, ACS nano.

[21]  R. M. Napoli,et al.  Behaviour of natural organic mater during ultrasonic irradiation , 2007 .

[22]  Arezou A Ghazani,et al.  Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. , 2006, Nano letters.

[23]  Conrad Coester,et al.  Particle and Fibre Toxicology BioMed Central Methodology , 2008 .

[24]  Wibke Busch,et al.  Physical-chemical characterization of tungsten carbide nanoparticles as a basis for toxicological investigations , 2010, Nanotoxicology.

[25]  A. T. Saber,et al.  Inflammatory and genotoxic effects of nanoparticles designed for inclusion in paints and lacquers , 2012, Nanotoxicology.

[26]  S. Hogekamp,et al.  Dispergieren und Desagglomerieren von Nanopartikeln mit Ultraschall , 2004 .

[27]  Pratim Biswas,et al.  Characterization of size, surface charge, and agglomeration state of nanoparticle dispersions for toxicological studies , 2009 .